Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 3,351–3,375 of 27,380 studies, newest first · page 135 of 1096.

August 2025 25

  1. 2025-08-28
  2. 2025-08-28

    Smart Room Design for Dementia Nursing Home Based on Kano-AHP-QFD Integrated Methodology

    ✓ Peer-reviewed Clinical safety HERD Health Environments Research & Design Journal

    Key finding: BackgroundWith the growing demand for dementia-friendly care environments, existing smart room designs often lack systematic methods to translate user needs into functional solutions. +4 more findings

  3. 2025-08-28

    MS4A6A/Ms4a6d deficiency disrupts neuroprotective microglia functions and promotes inflammation in Alzheimer’s disease model

    ✓ Peer-reviewed Inflammation and the immune system Molecular Neurodegeneration

    Key finding: We identified several new mutations of MS4A6A with altered AD risks, and discovered specific correlation for some of them with the amount of β-amyloid in cerebrospinal fluid. +4 more findings

  4. 2025-08-28

    Emerging Trends in Early Dementia Diagnosis: An Analysis on Advanced Machine Learning Approaches

    ✓ Peer-reviewed Digital health tools ACM Computing Surveys

    Key finding: Despite recent advances in dementia informatics research and AI, accurate early diagnoses are still far from ideal. +4 more findings

  5. 2025-08-28

    Acceptability of wearable technology for the early detection of dementia-causing diseases: perspectives from the CODEC II cohort

    ✓ Peer-reviewed Digital health tools BMC Digital Health

    Key finding: Five key themes were identified, including ease of use, wearability, usefulness, transparency, and behavioral intention. +4 more findings

  6. 2025-08-28
  7. 2025-08-28

    Age-related hearing loss and dementia risk across the lifespan: mechanisms, equity, and prevention

    ✓ Peer-reviewed Prevention and risk Neuroscience

    Key finding: Age-related hearing loss (ARHL) has emerged as a significant and potentially modifiable risk factor for neurodegenerative disorders, including Alzheimer's disease.

  8. 2025-08-27

    GLP-1 receptor agonist semaglutide ameliorates motor deficits and tau pathology in the rTg4510s mouse model

    ✓ Peer-reviewed Drug development Neuropharmacology

    Key finding: Semaglutide significantly improved motor coordination in rTg4510 mice on the pole test, though not rotarod endurance. +4 more findings

  9. 2025-08-27

    Burden of dementia following stroke subtypes: a study integrating the GBD database and Mendelian randomization

    ✓ Peer-reviewed Vascular contributions Journal of Stroke and Cerebrovascular Diseases

    Key finding: The relative risk of dementia following cerebral hemorrhage ( relative risk(RR):3.02[1.17-7.78],P<0.001 ) was higher than that of cerebral infarction (RR: 2.07[1.47-2.96], P<0.001). +4 more findings

  10. 2025-08-27
  11. 2025-08-27

    C-reactive protein predicts functional decline in older adults newly diagnosed with dementia: A 5-year follow-up study

    ✓ Peer-reviewed Cognitive tests and assessment Revista Española de Geriatría y Gerontología

    Key finding: A total of 158 participants were included, with an average age of 75.2 years (SD 7.65). 60.8% (n=96) of patients had AD, and 39.2% (n=62) had LBD. +3 more findings

  12. 2025-08-27

    Structural and functional insights into the selective inhibition of mutant tau aggregation by purpurin and oleocanthal in frontotemporal dementia

    ✓ Peer-reviewed Lewy body dementia Protein Science

    Key finding: Biophysical and cellular assays demonstrated that both compounds more effectively inhibit the aggregation of mutant tau peptides compared to wild-type, with PUR preferentially targeting V287I and N279K variants, and OLC showing broader inhibitory activity. +3 more findings

  13. 2025-08-27
  14. 2025-08-27

    Integrative machine learning approach to risk prediction for dementia and Alzheimer’s disease

    ✓ Peer-reviewed Digital health tools GeroScience

    Key finding: These findings highlight the value of integrating diverse data sources for dementia risk prediction and emphasize the role of sex-specific modeling and modifiable factors in early, personalized intervention strategies.

  15. 2025-08-27

    Neurodetector: EEG-Based Cognitive Assessment Using Event-Related Potentials as a Virtual Switch

    ✓ Peer-reviewed Getting a diagnosis Brain Sciences

    Key finding: The participants controlled the EEG Switch above chance level across all tasks. +4 more findings

  16. 2025-08-27

    Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia

    ✓ Peer-reviewed Getting a diagnosis Molecular Neurodegeneration

    Key finding: Forty-three proteins were differentially regulated in FTD compared to controls and AD, reflecting axon development, regulation of synapse assembly, and cell-cell adhesion mediator activity pathways. +4 more findings

  17. 2025-08-27

    Stepwise approach to alzheimer's disease diagnosis in primary care using cognitive screening, risk factors, neuroimaging and plasma biomarkers

    ✓ Peer-reviewed Tau biomarkers Scientific reports

    Key finding: We evaluated the diagnostic performance of a scalable, multimodal framework in a real-world, population-based cohort. +3 more findings

  18. 2025-08-27

    Plasma and neurostructural biomarkers in the clinical-biological characterization of early stages of the Alzheimer's disease continuum: findings from the Compostela Aging Study

    ✓ Peer-reviewed Tau biomarkers The journal of prevention of Alzheimer's disease

    Key finding: The main objective of this study was to contribute to the clinical-biological characterization of the initial stages of cognitive impairment by measurement of blood and neurostructural AD biomarkers in groups of participants classified according to their cognitive clinical phenotype. +3 more findings

  19. 2025-08-27

    Apolipoprotein E ε4-dependent associations between carotenoids and cognitive decline: Findings from the MIND (Mediterranean-DASH Intervention for Neurodegenerative delay) randomized controlled trial

    ✓ Peer-reviewed Treatments The American journal of clinical nutrition

    Key finding: Higher plasma carotenoid concentrations were associated with slower cognitive decline in APOE ε4 carriers, potentially mitigating genetic risk. +2 more findings

  20. 2025-08-26

    PM2.5 exposure exacerbates Alzheimer's disease pathology through lysosomal dysfunction in APP/PS1 mice

    ✓ Peer-reviewed Risk factors Ecotoxicology and environmental safety

    Key finding: Ambient fine particulate matter (PM2.5) is a key environmental risk factor closely associated with Alzheimer's disease (AD), although its specific molecular mechanisms remain incompletely elucidated. +3 more findings

  21. 2025-08-26

    Progress of radiomics research on white matter hyperintensity lesions

    ✓ Peer-reviewed Vascular contributions Frontiers in Neurology

    Key finding: This phenomenon is closely related to nervous system damage, such as cognitive impairment, dementia and increased risk of stroke. +1 more finding

  22. 2025-08-26

    Survival Variations Based on Hospice Qualifying Condition: A Retrospective Review

    ✓ Peer-reviewed End-of-life care American Journal of Hospice and Palliative Medicine®

    Key finding: The median survival duration overall was 17.36 days (Inter-quartile range 5.35-62.08). +1 more finding

  23. 2025-08-26

    Cognitive training gain transfer in cognitively healthy aging: per protocol results of the German AgeGain study

    ✓ Peer-reviewed Prevention trials Frontiers in Aging Neuroscience

    Key finding: Out of 180 subjects, 74 showed short-term training gain transfer that was maintained over 3 months in 19 subjects. +4 more findings

  24. 2025-08-26

    Navigation Between Alzheimer’s Disease (AD) and Its Various Pathophysiological Trajectories: The Pathogenic Link to Neuroimmunology—Genetics and Neuroinflammation

    ✓ Peer-reviewed Inflammation and the immune system International Journal of Molecular Sciences

    Key finding: Furthermore, type 2 diabetes (T2DM) and metabolic syndrome (MS) have also been observed to be early markers that may provoke pathogenic pathways that lead to or aggravate AD progression and pathology. +4 more findings

  25. 2025-08-26

Browse the library by subject, with the full score breakdown →